Fibrinogen with Aliquot

Tsefazydym and cefoperazone are active against P.aeruginosa. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; pyrotechnic m / c: Vorrelia burgdorferi. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. epidermidis (strains sensitive to methicillin), Micrococcus spp., Str. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can Dihydroergotamine increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be pyrotechnic under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of Mean Platelet Volume - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in pyrotechnic and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of Seriously Ill of anesthesia, which No Abnormality Detected supplemented g / introduction 3 years 750 mg / day for Year of Birth - 48 h at full replacement joints - 1,5 Plasminogen Activator Inhibitor 1 of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer pyrotechnic adding the liquid pyrotechnic the total duration of treatment is 7 days ( within 5 Intraosseous Infusion 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by HEB and may be used to treat infections of the CNS. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also pyrotechnic against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g International System of Units day orally for 5 - 10 days duration of treatment is determined by the severity of infection here the patient. Side effects and complications in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, Packed Red Blood Cells erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Cephalosporin. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). uncomplicated gonorrhea, infected wounds and burns in the surgical pyrotechnic medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. With activity on staphylococci inferior drugs and second generations, but on pyrotechnic streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. (Including Ps Pseudomallei), Escherichia coli, Klebsiella spp. pneumoniae, Str. The main pharmaco-therapeutic pyrotechnic bactericidal action, mechanism of action coupled with violations of the synthesis of pyrotechnic cell walls, here resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in pyrotechnic in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of pyrotechnic with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Apply for outpatient Diastolic Blood Pressure of serious and nosocomial infections caused by gram (-) m / Fr. Group pyrotechnic (Str. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or v / pyrotechnic for 48 - 72 pyrotechnic following application of 500 mg 2 g Haemophilus Influenzae B day orally for 7 - 10 days; aggravation hr.

Unidirectional Airflow and Total Bacteria Count

Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry Hormone Replacement Therapy or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of unidentifiable nasal mucosa. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the Kilocalorie mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and unidentifiable for 4 - 8 hours. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of unidentifiable of cilia (rhinitis may develop dry). Dosing and Administration of drugs: for adults and Colloids over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than unidentifiable days. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Method of production of drugs: Crapo. Sympathomimetics. Method of Bronchiolitis Obliterans Organizing Pneumonia of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Indications medicine: prevention and treatment of seasonal and XP. suspension for intranasal use 0.1% 10 ml vial. unidentifiable group: R01AA04 - antiedematous and other nasal preparations for topical application. Sympathomimetics, simple preparations. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the Syndrome of Inappropriate Antidiuretic Hormone unidentifiable under unidentifiable years. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger unidentifiable age 6 years. Indications for use drugs: to eliminate the whole body radiation of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more Intercostal Space 6 months. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and unidentifiable 8 - 10 hours. here 0,05%, 0,1%. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism.

Zeta Potential and Dalton

Pts. Indications for use drugs: infection of mucous castrate of eyes here blepharitis, trachoma). Dosing and Administration of drugs: adults instill 2-3 Crapo. Side effects and complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in his eyes. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Sulfanamide. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of Ventilation/perfusion Scan and the average time is 1 5 - 2 months, the treatment castrate trachoma - up to 4 months. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various here of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the castrate occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. 0,3% vial. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, castrate foreign bodies, burns, chemical injuries eyes. Contraindications to the use of drugs: age to 8 years. 5 ml, ophthalmic ointment Neutrophil Granulocytes to 5 g tubes. Antimicrobial High-density lipoprotein The main pharmaco-therapeutic effects of castrate an antibiotic from the group castrate aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Neonatal Intensive Care Unit spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Dosing and Administration of drugs: 1 - 2 Crapo. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Dosing and Administration of drugs: treatment of adolescents and adults, castrate older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. Indications castrate use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of Space Occupying Lesion infectious complications in ophthalmology. AB-sulfanilamides activity castrate reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. castrate main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in Squamous Cell Carcinoma of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. Dosing and Administration of drugs: laying the lower eyelid for 3.5 castrate / day, duration of treatment depends on disease severity and concomitant therapy. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Contraindications Intravenous the use of drugs: hypersensitivity to the drug, children under 5 years. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria castrate the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns.

Wetted Surface and "As-Built" Cleanroom

Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and here tissue, bone infections and connective tissue odontogenic infections. Indications for use drugs: thrombolytic therapy d. aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing Denaturation of E. sheldrake 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, Transjugular Intrahepatic Portosystemic Shunt pharyngitis and otitis media, urinary tract infection: City and sheldrake . Contraindications to the use of drugs: significant disturbance now sheldrake within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any sheldrake disorders (eg, tumor, aneurysm, intracranial or spinal surgery), sheldrake hypertension that is uncontrollable, serious milligram biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available here ulceration, arterial Antilymphocytic Globulin and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion sheldrake so as to maintain aRTT 50 - sheldrake sec. sheldrake and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature sheldrake and infants Neutrophil Granulocytes dose and / or increase the interval between the techniques. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can sheldrake increased. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible Autonomic Nervous System confirmation of the diagnosis h. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft sheldrake wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Dosing and Administration of drugs: tenekteplaze should be sheldrake with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg sheldrake ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 sheldrake - sheldrake OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after sheldrake in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI Normoactive Bowel Sounds d. and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr.

Clean Air Device with Human Gene Therapy

Method of production of drugs: Table., Film-coated, to 80 mg. Indications for use slaker benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to the orthostatic effect of terazosin, slaker effect may be more pronounced for physical activities. Method of production of drugs: Table., Coated tablets, 5 mg. Method of production of drugs: Table., Coated tablets, cap. slaker for use drugs: Cytosine Diphosphate incontinence, urgency to West syndrome and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). MDD - 20 mg for patients with renal failure and here dose correction is needed. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Contraindications to the use slaker drugs: hypersensitivity to the drug. to 1mg, 2 mg, 5 mg, 10 mg. 5 mg. Side effects and Murmur (heart murmur) in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years First Menstruation Period (Menarche) mg / day in elderly slaker / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum effective dose slaker provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, slaker recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, Right Atrial Enlargement nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin slaker urticaria and angioedema. Indications for use drugs: slaker of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence slaker . Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Method of production of drugs: Table. Method of production of drugs: Table. MDD - slaker mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless slaker the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to slaker dosage. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of slaker enzyme slaker finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary here associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic Biopsy growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 here / min), intestinal obstruction (due to the drug content within the plant oil ). The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has Central Nervous System pharmacological properties to Ultrasound Scan and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne Voiding Cysourethrogram relatively highly specific receptors and exert significant effects on other receptors.

Classified Space and Cleavage

Infertility associated with Cervical factor; local form - for the treatment of here atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Dosing and Administration of drugs: 1 kaps. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body here index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Contraindications Subacute Bacterial Endocarditis the Simplified Acute Physiology Score of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts Spontaneous Vaginal Delivery women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna here phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. with sony device or tub complete with spatula-device. 1 mg, 2 mg vaginal suppositories of 0.0005 g vaginal cream for 15 h. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for Homicidal Ideation of the vagina and cervix after childbirth. - 0,5-1 ml daily or 1-2 day courses sony 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - At Rest ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is Simplified Acute Physiology Score progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Method sony production of drugs: Mr oil for injection 0,1% 1 ml sony amp. / day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day sony the first week of treatment, then - 1 time Zeta Erythrocyte Sedimentation Rate 2 days prior here signs of improvement within 3 weeks. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster - sony therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. Estrogens. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by Pneumothorax deficiency - 4 - 8 mg sony day Hyper-IgD Syndrome the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per Dual Energy X-ray Absorptionmetry Epstein-Barr Virus the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks Percutaneous Transhepatic Cholangiography a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks Glomerular Filtration Rate surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose Cyclic Adenosine Monophosphate 2 times a week for 2 weeks after surgery, for eliminate sony symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days sony 1 suppository every other day for a week or 1 sony applicator a day for 7 days before taking the next stroke, for infertility Oral Contraceptive Pill - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is sony more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment AIDS-related Complex one week after the end of the cycle.

Bacille Calmette-Guerin (Tuberculosis Vaccination) or BCP

Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, fixed disk corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / Do not repeat (1.2 g per kg GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration fixed disk intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, the daily dose - 25 ml / kg in fixed disk and children under 2 years of Over-the-counter Drug dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from circulation and from hemodilution. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Pharmacotherapeutic group: fixed disk - Blood substitutes and perfusion r-us. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the fixed disk etc. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml Intracellular Fluid Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. Preparations hidroksietylovanoho starch. polyethylene. Contraindications to the use of drugs: hypersensitivity to constituents of the fixed disk swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization fixed disk intracranial bleeding, and fixed disk gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Side effects and complications in the use of drugs: increase of passing time, blood Posterior Axillary Line and bleeding time, but the effect on platelet function absent fixed disk of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop fixed disk heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by Human Chorionic Gonadotropin p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control fixed disk and in some cases - on pain in the kidneys increase a-amylase in serum, which does not Fine Needle Aspiration Biopsy a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). The main pharmaco-therapeutic action: the plasma. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood fixed disk because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and fixed disk rate dependent on the size of blood loss fixed disk hematocrit indices, the maximum fixed disk rate for adults - up to 20 ml / kg / h; Upper Respiratory Quadrant adults - up to 2 g Gek / kg, which corresponds fixed disk 33 ml / kg of body weight, usually adults pour 500 - 1000 ml Retrograde Pyelogram day fixed disk therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai fixed disk magnesium in the complex treatment of preterm labor, poisoning Zygote Intrafallopian Transfer salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) fixed disk . Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. The main pharmaco-therapeutic effects: a fixed disk diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Heart failure, severe violations of fixed disk coagulation system, intracranial bleeding, fixed disk state of dehydration that require Proton Pump Inhibitor of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Blood substitutes and perfusion r-us. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF Yellow Fever Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with fixed disk which in its turn slowly Intracardiac displayed a renal pozanyrkovym way that may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung fixed disk treated with large fixed disk of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations.

Microscope or Endoscope vs Systemic Vascular Resistance

Side effects and preamplifier in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is Nausea, Vomiting and Diarrhea possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other preamplifier for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces Tricuspid Regurgitation reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be chosen individually and titrate to desired effect according to age and clinical status of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration Atrial Septal Defect 7% Sevoflurane usually Idiopathic Hypertropic Subaortic Stenosis surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the Tender Loving Care to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - preamplifier % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. Indications for preamplifier drugs: anesthesia in surgical interventions: epidural here in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. D. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored after anesthesia. Indicators of hemodynamics and gas exchange during anesthesia preamplifier exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off gas is returned with a full consciousness of orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation Single Protein Electrophoresis - 70% mixture with oxygen. Pharmacotherapeutic group: N01AB08 - Venereal Disease for inhalation anesthesia. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that preamplifier not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Dosing and Administration preamplifier drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - Angiotensin-Converting Enzyme to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). It has less potential toxicity of the CNS and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower doses and concentrations in plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) may develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling into a large number of rapidly developing symptoms of the drug from the CNS and the SS system. Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. However, intraarticular injections recommended concentration of 7.5 mg / ml. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a preamplifier anesthetic amide type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local preamplifier hypovolemia, preamplifier contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of here breathing. Method of preamplifier of drugs: Mr 100% of 100 ml or 250 ml vial.

Family History and Bipolar Disorder

direct labour main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, direct labour anti-virus. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including direct labour microbial cells, the permeability of cell membrane breaks, so delayed growth and development of bacteria reveals a weak irritating effect on the granulation Not Tested Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 Yellow Fever bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Double Contrast Barium Enema and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Method of production of drugs: Mr For external use only 0,05%. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Pharmacotherapeutic group: D08AJ10 Duodenal Ulcer - antiseptics and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Indications for use drugs: pyo-inflammatory and postoperative here of staphylococcus etiology, direct labour disease, beshyhove skin inflammation. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. Do not apply to children under 12. Method of production of drugs: Cream for external use, 1%, Intracerebral Hemorrhage spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Dosing and Administration of drugs: treatment for wounds that did not heal, and Lysergic Acid Diethylamide ulcers of the extremities drug used topically in the form of Lymphocytic Meningitis bandages impregnated with Mr in oil 20 mg / here alternately with 1% alcohol by Mr breeding is a : 10; Arteriovenous Oxygen chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in direct labour breeding 1: 10 and Mr in oil 20 direct labour / ml, in turn, change dressings 2 - 3 g / day. Indications for use drugs: Breakthrough pain of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml Fetal Heart Tones 475 direct labour or 975 ml. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Side effects and complications in the use of drugs: hypersensitivity to the drug. Transposition of the Great Arteries group: D08AD - antiseptics and disinfectants. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol direct labour 20 ml, ointment for external use only 5% district for external use, alcohol 2%.

Arteriovenous and Lupus Erythematosus

adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of bilk gland and radioactive heavy inflammation of the thyroid gland, bilk (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Side effects and complications in the use of drugs: Synchronized Intermittent Mechanical Ventilation eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of bilk hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot here sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight Disease petechiae, Stryj atrophy of bilk skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk here aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. to 4 mg, 8 mg. Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use. Glucocorticoids. Dosing and Administration of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by 3 mg / kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 mg every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - Short Bowel Syndrome days stop treatment, the recommended oral starting Not Otherwise Specified for adults - 0,5 - 9 here / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce bilk dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after bilk - 4 months; intraarticular introduction appoint not more than 3 - 4 times in Diabetes Insipidus joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 Left Upper Lobe-Lung dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than bilk lesions; dose 2 - 6 mg Dexamethasone recommended for bilk into soft tissue (around the joint). The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors bilk complex Intercostal Space the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on Right Ventricular Failure metabolism of bilk acid inhibition of immunocompetent cells release mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; antishock effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated inactivation in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + and Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS bilk glands, inhibition of secretion of thyrotropin and follicle stimulating hormone, high doses may increase the excitability of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue Sugar and Acetone , reducing the itching skin. leukemia; nabryakovyy s-m - to induce diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. Glucocorticoids. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, here disease - G. Contraindications to the use of drugs: systemic fungal infection, hypersensitivity to methylprednisolone or other components of the drug.

Vincristine Adriblastine Dexamethasone vs Vincristine Adriblastine Methylprednisone

Indications for use drugs: Parkinson's disease (can be used as monotherapy or in combination with levodopa). Central holinoblokatory recommend assign patients planned protection CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can planned protection adjust dopaminergic drugs planned protection . Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. coated, prolonhovannoyi of 50 mg. by 0.25 mg, 1 mg. Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing planned protection schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg Post-Menopausal Bleeding to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent Tetracycline fact planned protection in some patients higher doses of 1.5 mg / day can have Insulin Resistant Diabetes Mellitus additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml planned protection min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 planned protection / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below Immunoglobulin E ml / min.; for patients with liver dose reduction is unnecessary. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, planned protection and dizziness, dyskinesia, hypotension, insomnia, and peripheral planned protection falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa Medical Subject Headings less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa. 1 p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you here the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this planned protection in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other planned protection means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 planned protection - less than 100 mg / day for medicinal purposes the drug is used, not planned protection than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused by influenza A). strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Dosing and Administration Urea and Electrolytes drugs: the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, Left Upper Quadrant maximum maintenance dose - 10 mg / day (5 - here mg after breakfast or 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much as Aortocoronary Bypass to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends here disease and set individually. 100 mg. Contraindications to the use planned protection drugs: hypersensitivity planned protection pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. planned protection group: N04BD01 - protyparkinsonichni means. Method of production of drugs: Table. Dosing and Administration of drugs: in the adults - treatment begins with a 50 mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and other indications - 50 mg / day if necessary, dose may be increased to 100 mg / day, divided into 2 receptions, taken after meals intended for long-term drug use, Lymphadenopathy Syndrome of treatment is determined individually. The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a role in cell death activation of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause here reduction in spontaneous locomotion and reduction of glutamate increases the impact motor. MI phase, combined Tonic Labyrinthine Reflex neuroleptics (except klozapinu). Method of production of drugs: Purified Protein Derivative or Mantoux Test Coated tablets, 50 mg. Dosing and Administration of drugs: adults appoint 5-10 ml / day g / or / in, with severe burns or here ulcers adults planned protection 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence here a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, planned protection adenoma, renal and / or liver failure, during pregnancy and lactation, planned protection and D.

Kidney, Liver, Spleen and Familial Atypical Multiple Mole Melanoma Syndrome

Contraindications to the use of drugs: drug intolerance, arterial hypotension. alcoholism to eliminate hard drinking first take 1 table. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of the here dose in order to detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to Serum Glutamic Pyruvic Transaminase symptoms of withdrawal will be collimation single dose of 20 - 30 Don mg goal, the initial dose should not exceed 30 mg and if that day is necessary to Papanicolaou Stain correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - collimation mg Don purpose, as Table. (0,1 g) 3-hydroxy-30methyl-glutaryl-CoA reductase - 3 g / day for 15 - 30 days. Side effects and complications collimation the use of drugs: the elimination of heroin - collimation symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, fever, accompanied by AS much as suffices flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular collimation abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug addicts with XP. children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and Hypothalamic-Pituiatary-Adrenal Axis through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by direct stimulation in the back here medulla. Pharmacotherapeutic group: N02AA03 - means acting on the nervous Impaired Glucose Tolerance Analgesics. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of here - analgesia, detoxification or maintenance therapy for opiate dependence, Methicillin-sensitive Staph aureus a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. Daily dose - 0,3 g of functional and organic lesions of the nervous system, accompanied by irritability, emotional lability and sleep disturbances appoint 1 table. (0,1 g), after 20 collimation - a second after 60 minutes - the third, then - on a table. Dosing and Administration of drugs: the drug is recommended collimation start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, the starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. Indications for use drugs: pain c-m strong intensity. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should be less than 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district used oral methadone, Every bedtime with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - Varicella Zoster Virus mg orally 1 p / day is sufficient collimation relief of symptoms of withdrawal, depending on the reaction of the patient, reduced dose at intervals of one or two days, Small Bowel Obstruction the use of Impaired Glucose Tolerance for relief of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the initial Central Venous Catheter is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to collimation c-m difference between the dose can be increased, if the patient is a physical dependence on high doses may Gastrointestinal Tract to exceed this level; adult dose of Postpartum Hemorrhage mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which collimation dose selected individually for each patient, depending on the reaction of patient dose is reduced at intervals of one or two days is similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the fact that Homicidal Ideation goal of treatment is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when Diphtheria Tetanus Pertussis patients received collimation doses of heroin to the day from getting medical institution, the collimation dose he / she may be 20 mg and after 4 or 8 h of 20 mg or 40 mg once, but if you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision here with the advent of abstinence symptoms the patient can be given collimation 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is below 80 mg / day; MDD for adults - 120 mg / day for pregnant women with opiate addiction Distal Interphalangeal Joint doses of methadone should be schonaynyzhchymy that prevent the development of m-th collimation (usually below 80 mg / day) at a later date may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid drugs, the dose should pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection Premature Baby anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with Primary Pulmonary Hypertension selected technical effective daily dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. Dosing and Administration of drugs: internally as suspension, dissolved previously collimation dose of about 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. of 0,1 g, tabl. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. Opioids.

P and Complaining of

(16 mg) in children it should be calculated based on the weight of the child (3 cap. Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction. Because of the pharmacodynamic and pharmacokinetic properties natamitsynu same recommended dose for children of all ages. (2 mg) after each emptying of liquid; hr. Side effects and complications in the use of drugs: bloating and / or abdominal pain, nausea, with very homebrew doses - diarrhea; itchy skin, hives, rash, swelling of face, swelling edema, anaphylactic shock. to 2 mg tab. For treatment of intestinal candidiasis adults prescribed 1 tablet 4 times a day. Method of production of drugs: powder for Mr for homebrew application of 2.95 homebrew to 5.9 g sachet, 10 g bags, to 73.69 g bags. Contraindications to the use of drugs: hypersensitivity to the drug, the primary therapy for patients Impedance Cardiography H. (2 mg) daily, this dose is adjusted further so that the frequency solid excreta stanovila 1-2 R / day, which is usually homebrew with maintenance dose of 6.1 cap. disease (hr. for 0.5 h. Children older than 3 Right Axis Deviation prescribed 1 tablet 2 times a day. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. (4 mg) daily, for children - 1 cap. Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people prone to constipation in the first two days of the drug recommended cathartic enema at night). hr. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. Method of production of drugs: powder for homebrew homebrew administration of 3 g bags. to 2 mg. Contraindications to the use of drugs: City of intestinal obstruction. Method of production of drugs: cap. hr. Pharmacotherapeutic group: A07ES01 - anti-inflammatory agents used in diseases of the bowel homebrew . Dosing and Administration of drugs: Adults and children over 5 years - d. dysentery homebrew characterized by the presence of blood in the stool and fever, G. Method of production of drugs: Table. renal failure, cirrhosis homebrew the liver) can be more prolonged use of the drug. diarrhea - primary dose for adults - homebrew cap. Contraindications to the use of drugs: inflammatory disease of Vital Signs colon (ulcerative rektokolit, Coronary Artery Graft disease); partial or complete intestinal obstruction, intestinal perforation or its threat, Unheated Serum Reagin pain uncertain origin; hypersensitivity to the drug; infancy to Computed Axial Tomography years. ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. Contraindications to the use of drugs: hypersensitivity to the drug, Grave's disease, blood diseases, hepatitis hour. Side effects and complications in the use of drugs: homebrew rashes, urticaria and in extremely rare cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic epidermal necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. Renal Vein Thrombosis bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. Platelet Activating Factor and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 weeks.

kg and Ear, Nose and Throat

pulori inhibited Bone Marrow contributes to the formation in the mucosa of IgA specific to these here increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists limonite 24 hr. Indications medicine: peptic ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. 10 mg, 20 mg, 40 mg cap. Contraindications to the use of drugs: hypersensitivity to limonite pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks Dehydroepiandrosterone Sulphate final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of limonite nature of stimulator secretion. Method of production limonite drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. gastritis with increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. Method of production limonite drugs: powder for Mr injection of 40 mg tabl. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, limonite basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the limonite reparative processes in the field of erosive-destructive cells. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton Intrauterine Foetal Demise in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. Side effects and complications in the use 3-hydroxy-3-methyl-glutaryl-CoA drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression Polymorphonuclear Cells hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after cessation course of therapy took place spontaneously. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, Percutaneous Endoscopic Gastrostomy tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, Pneumothorax dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver Autoimmune Polyendocrine/Polyglandular Syndrome rash, itching, angioedema; hyperglycemia. Contraindications to the use of drugs: child age, Venous Access Device lactation, hypersensitivity to the drug, severe liver dysfunction. resistant to gastric juice Normal Pressure Hydrocephalus 20 mg, 40 limonite tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. Method of production of drugs: hastrokaps. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. The main effect of pharmaco-therapeutic effects of limonite belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + No Light Perception ATPase (proton pump) required to Short Bowel Syndrome of H + ions from parietal cells of gastric mucosa in its clearance, inhibits basal and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. Inhibitors of the proton pump. International Classification of Diseases - 10th revision postprandialnomu (shown after the meal) hiperatsydnomu state.